OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
26120056

Dentis Co Ltd

Medical Equipment, Supplies & DistributionVerified

Dentis Co Ltd operates with a capital structure that shows a debt-to-equity ratio of 2.35, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.74, suggesting that its current liabilities exceed its current assets. Additionally, the company has negative net cash after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, Dentis Co Ltd is currently unprofitable, with a return on equity of -0.3057 and a return on assets of -0.0679. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in the Medical Equipment, Supplies & Distribution industry. The company's revenue is primarily concentrated in its core segments, which include dental implants, 3D printing, and biomaterials. However, the input data does not provide specific geographic revenue breakdowns, so it is unclear whether the company has significant exposure to any particular region. Dentis Co Ltd's growth trajectory is uncertain, as the company reported a net loss in the latest financial period. The outlook for the current fiscal year does not provide specific numeric deltas for revenue growth, but the negative operating and net income figures suggest a challenging environment. The company's capital expenditures were -3943427870 KRW, indicating a reduction in investment in new assets. The risk assessment for Dentis Co Ltd highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential difficulties in meeting short-term obligations. The dilution risk is considered low, and there are no immediate signs of dilution pressure from recent issuance or shelf registration. Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The latest financial snapshot indicates a challenging operating environment, with negative operating and net income figures. The company's free cash flow is also negative, suggesting that it is not generating sufficient cash from operations to fund its activities.

30-day price · 261200-520.00 (-13.6%)
Low$3305.00High$4150.00Close$3310.00As of21 May, 00:00 UTC
Profile
CompanyDentis Co Ltd
Ticker261200.KQ
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Dentis Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of medical devices, including dental implants, 3D printers, biomaterials, prosthetics, and surgical instruments.

Classification. Dentis Co Ltd is classified under the Healthcare Services & Equipment business sector within the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

Dentis Co Ltd operates with a capital structure that shows a debt-to-equity ratio of 2.35, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.74, suggesting that its current liabilities exceed its current assets. Additionally, the company has negative net cash after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, Dentis Co Ltd is currently unprofitable, with a return on equity of -0.3057 and a return on assets of -0.0679. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in the Medical Equipment, Supplies & Distribution industry. The company's revenue is primarily concentrated in its core segments, which include dental implants, 3D printing, and biomaterials. However, the input data does not provide specific geographic revenue breakdowns, so it is unclear whether the company has significant exposure to any particular region. Dentis Co Ltd's growth trajectory is uncertain, as the company reported a net loss in the latest financial period. The outlook for the current fiscal year does not provide specific numeric deltas for revenue growth, but the negative operating and net income figures suggest a challenging environment. The company's capital expenditures were -3943427870 KRW, indicating a reduction in investment in new assets. The risk assessment for Dentis Co Ltd highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential difficulties in meeting short-term obligations. The dilution risk is considered low, and there are no immediate signs of dilution pressure from recent issuance or shelf registration. Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The latest financial snapshot indicates a challenging operating environment, with negative operating and net income figures. The company's free cash flow is also negative, suggesting that it is not generating sufficient cash from operations to fund its activities.
Key takeaways
  • Dentis Co Ltd is currently unprofitable, with a return on equity of -0.3057 and a return on assets of -0.0679.
  • The company has a debt-to-equity ratio of 2.35, indicating a high reliance on debt financing.
  • The company's liquidity position is weak, with a current ratio of 0.74 and negative net cash after subtracting total debt.
  • The company's growth trajectory is uncertain, with negative operating and net income figures.
  • The risk assessment highlights a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$114.25B
Gross profit$49.52B
Operating income-$10.78B
Net income-$14.20B
R&D
SG&A
D&A
SBC
Operating cash flow-$9.69B
CapEx-$3.94B
Free cash flow-$13.43B
Total assets$209.11B
Total liabilities$162.66B
Total equity$46.45B
Cash & equivalents$6.88B
Long-term debt$109.37B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$114.25B-$10.78B-$14.20B-$13.43B
FY-1$114.28B-$1.37B$2.94B-$9.20B
FY-2$94.33B$421.4M$3.83B-$19.79B
FY-3$87.09B$5.57B$1.23B-$1.95B
FY-4$65.74B$367.0M$606.7M-$5.85B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$209.11B$46.45B$6.88B
FY-1$214.25B$55.33B$5.04B
FY-2$187.64B$55.46B$17.14B
FY-3$131.07B$29.49B$7.89B
FY-4$115.93B$31.45B$6.05B
PeriodOCFCapExFCFSBC
FY0-$9.69B-$3.94B-$13.43B
FY-1-$5.36B-$16.95B-$9.20B
FY-2-$9.38B-$26.91B-$19.79B
FY-3$5.17B-$5.64B-$1.95B
FY-4-$571.5M-$8.64B-$5.85B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$22.77B-$9.92B-$8.12B-$7.17B
FQ-1$26.59B-$1.57B-$623.3M-$1.47B
FQ-2$32.40B-$308.2M-$5.14B-$5.30B
FQ-3$32.48B$1.02B-$310.2M-$20.0M
FQ-4$25.64B-$5.86B-$1.17B-$550.9M
FQ-5$29.69B$1.06B-$2.75B-$3.16B
FQ-6$30.38B$2.01B$3.69B-$445.1M
FQ-7$28.57B$1.42B$3.17B-$5.05B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$209.11B$46.45B$6.88B
FQ-1$218.78B$53.96B$7.43B
FQ-2$214.84B$55.09B$7.27B
FQ-3$214.30B$55.39B$4.55B
FQ-4$214.25B$55.33B$5.04B
FQ-5$211.48B$60.41B$4.59B
FQ-6$214.34B$59.40B$7.51B
FQ-7$201.31B$58.40B$3.58B
PeriodOCFCapExFCFSBC
FQ0-$9.69B-$3.94B-$7.17B
FQ-1-$11.12B-$3.40B-$1.47B
FQ-2-$9.06B-$2.13B-$5.30B
FQ-3-$3.73B-$997.6M-$20.0M
FQ-4-$5.36B-$16.95B-$550.9M
FQ-5-$3.57B-$16.24B-$3.16B
FQ-6-$312.3M-$14.70B-$445.1M
FQ-7$1.36B-$9.04B-$5.05B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$46.45B
Net cash-$102.49B
Current ratio0.7
Debt/Equity2.4
ROA-6.8%
ROE-30.6%
Cash conversion68.0%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric261200Activity
Op margin-9.4%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-12.4%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin43.3%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-3.5%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity235.0%69.3% medp25 63.4% · p75 74.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:32 UTC#2a99bbb3
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:35 UTCJob: 9e77c01f